The objective of the Biostatistics and Research Information Shared Resource is to provide collaborative and consultative services to Stanford Cancer Center investigators and thereby add value in all phases of cancer research. Capabilities include high-quality biostatistics consultation on the use of standard methods as well as innovation in developing methods specifically to enhance the basic and translational research efforts of a discovery-oriented Cancer Center faculty. As a dedicated core with a clear means of access, the Biostatistics Shared Resource greatly benefits those researchers in need of statistical collaboration and consultation in their studies. Since official inception of this Shared Resource in 2005, more than 200 Cancer Center members representing all ten Research Programs have been assisted through the Biostatistics Shared Resource. Significant additional contributions by staff in this Shared Resource include new methods in microarray data analysis and genetic association studies, as well as innovative designs for clinical trials. The core also advises on strategic issues with statistical content, such as criteria for scientific review and development of databases and registries. It provides support to the Northern California Cancer Center, with a dedicated on site senior biostatistician staff member who is responsible for first point of contact and access to the entire Resource. The Shared Resource has responsibility for supporting the development of a Research Database for the Cancer Center, an effort that is currently underway, using methods that have been successfully deployed in two landmark programs (Lymphoma and Hematopoetic Cell Transplant) in the Cancer Center. The Shared Resource is also responsible for caBIG ? activities at Stanford.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA124435-04
Application #
8181133
Study Section
Subcommittee G - Education (NCI)
Project Start
2010-09-15
Project End
2015-05-31
Budget Start
2010-09-15
Budget End
2011-05-31
Support Year
4
Fiscal Year
2010
Total Cost
$216,089
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Thorsson, Vésteinn; Gibbs, David L; Brown, Scott D et al. (2018) The Immune Landscape of Cancer. Immunity 48:812-830.e14
Rogers, Zoë N; McFarland, Christopher D; Winters, Ian P et al. (2018) Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice. Nat Genet 50:483-486
Nair, Viswam S; Sundaram, Vandana; Desai, Manisha et al. (2018) Accuracy of Models to Identify Lung Nodule Cancer Risk in the National Lung Screening Trial. Am J Respir Crit Care Med 197:1220-1223
She, Richard; Jarosz, Daniel F (2018) Mapping Causal Variants with Single-Nucleotide Resolution Reveals Biochemical Drivers of Phenotypic Change. Cell 172:478-490.e15
Champion, Magali; Brennan, Kevin; Croonenborghs, Tom et al. (2018) Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response. EBioMedicine 27:156-166
Zhou, Mu; Leung, Ann; Echegaray, Sebastian et al. (2018) Non-Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications. Radiology 286:307-315
Pollom, Erqi L; Fujimoto, Dylann K; Han, Summer S et al. (2018) Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival. J Radiat Res 59:i11-i18
Nørgaard, Caroline Holm; Jakobsen, Lasse Hjort; Gentles, Andrew J et al. (2018) Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow - A proof of concept study. PLoS One 13:e0193249
Im, Hogune; Rao, Varsha; Sridhar, Kunju et al. (2018) Distinct transcriptomic and exomic abnormalities within myelodysplastic syndrome marrow cells. Leuk Lymphoma 59:2952-2962
Huang, Min; Zhu, Li; Garcia, Jacqueline S et al. (2018) Brd4 regulates the expression of essential autophagy genes and Keap1 in AML cells. Oncotarget 9:11665-11676

Showing the most recent 10 out of 322 publications